HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claudin-4 as a marker for distinguishing malignant mesothelioma from lung carcinoma and serous adenocarcinoma.

Abstract
We compared claudin-4 with Ber-EP4 and carcinoembryonic antigen as markers to distinguish mesothelioma from lung adenocarcinoma, poorly differentiated lung squamous cell carcinoma, and serous adenocarcinoma of the uterus or ovary. All mesothelioma specimens were negative for claudin-4, but 3 of 18 specimens were focally positive for Ber-EP4. In contrast, lung adenocarcinoma including poorly differentiated adenocarcinoma was highly positive for claudin-4, but expression of Ber-EP4 and carcinoembryonic antigen varied widely. Claudin-4 in poorly differentiated squamous cell carcinoma had a lower positive expression rate than in adenocarcinoma. Granular claudin-4 immunoreactivity was conspicuous in poorly differentiated squamous cell carcinoma; this immunoreactive pattern was also observed in mesothelioma. Claudin-4 was thus considered very useful marker for distinguishing mesothelioma and adenocarcinoma, even if histological specimens are small, as in biopsies that contain limited numbers of tumor cells. However, it should be mentioned that claudin-4 has a limit in discrimination between squamous cell carcinoma from mesothelioma.
AuthorsYoshiki Ohta, Yosuke Sasaki, Mitsuji Saito, Miki Kushima, Masafumi Takimoto, Akira Shiokawa, Hidekazu Ota
JournalInternational journal of surgical pathology (Int J Surg Pathol) Vol. 21 Issue 5 Pg. 493-501 (Oct 2013) ISSN: 1940-2465 [Electronic] United States
PMID23775021 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Claudin-4
Topics
  • Biomarkers, Tumor (analysis)
  • Carcinoma, Squamous Cell (diagnosis, metabolism)
  • Claudin-4 (analysis, biosynthesis)
  • Cystadenocarcinoma, Serous (diagnosis, metabolism)
  • Diagnosis, Differential
  • Female
  • Humans
  • Immunohistochemistry
  • Lung Neoplasms (diagnosis, metabolism, secondary)
  • Mesothelioma (diagnosis, metabolism)
  • Ovarian Neoplasms (diagnosis, metabolism)
  • Uterine Neoplasms (diagnosis, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: